Clinical indications for Gallium-68 positron emission tomography imaging
Authors:
- S. KhanSKS. Khan
- S. El-RefaieSES. El-Refaie
- Z. WinZWZ. Win
- D. RubelloDRD. Rubello
- A. Al-NahhasAAA. Al-Nahhas
- 1 June 2009
- journal article
- review article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 35 (6) , 561-567
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga‐DOTATATE (DOTA‐DPhe1,Tyr3‐octreotate) and 18F‐FDGCancer, 2008
- Gastroenteropancreatic neuroendocrine tumoursThe Lancet Oncology, 2008
- 68Ga-DOTATATE PET in neuroectodermal tumours: First experienceNuclear Medicine Communications, 2007
- Metastatic Carcinoid Tumors: A Clinical ReviewThe Oncologist, 2005
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003
- Somatostatin and Its Receptor FamilyFrontiers in Neuroendocrinology, 1999
- Visualization of the thymus by substance P receptor scintigraphy in manEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Pheochromocytoma: Diagnosis, Localization and ManagementNew England Journal of Medicine, 1984
- Comparison of 68Ge/68Ga generator systems for radiopharmaceutical productionThe International Journal of Applied Radiation and Isotopes, 1984
- A review of radiopharmaceutical development with short-lived generator-produced radionuclides other than 99TcThe International Journal of Applied Radiation and Isotopes, 1977